Former FDA head urges ethics for off-label promotion

Access to the full content of this site is available only to registered healthcare professionals. Register to read more

Takeaway

  • Drug marketers need to police themselves with a code of ethics on off-label marketing of their products because it continues to be essentially unregulated, former US Food and Drug Administration (FDA) commissioner Robert Califf, MD, told an industry audience.

Why this matters

  • The actions of unscrupulous industry marketers can paint the industry in a negative light and potentially harm patients without a clear set of rules, said Dr. Califf, a cardiologist who headed the agency from February 2016 to January 2017.
  • "Your efforts should be truthful and nonmisleading,...